Dr. Muntasir Mamun Majumder - Institue for Molecular Medicine - Post Doctoral Fellow

Dr. Muntasir Mamun Majumder

Institue for Molecular Medicine

Post Doctoral Fellow

Helsinki | Finland

Main Specialties: Hematology, Hematology & Oncology, Medical Genetics, Pharmacology

Additional Specialties: Personalized Medicine, High Throughput Assays, Hematology, Myeloma, AML, CMML

Dr. Muntasir Mamun Majumder - Institue for Molecular Medicine - Post Doctoral Fellow

Dr. Muntasir Mamun Majumder

Introduction

Primary Affiliation: Institue for Molecular Medicine - Helsinki , Finland

Specialties:

Additional Specialties:


View Dr. Muntasir Mamun Majumder’s Resume / CV

Education

Nov 2018
Institute for Molecular Medicine Finland
Post Doctoral Scientist
Oct 2018
Institute for Molecular Medicine Finland
Ph.D in Precision Medicine
Jun 2010
Stockholm University
MSc in Toxicology

Publications

13Publications

279Reads

20Profile Views

354PubMed Central Citations

Drug combination sensitivity scoring facilitates the discovery of synergistic and efficacious drug combinations in cancer.

PLoS Comput Biol 2019 May 20;15(5):e1006752. Epub 2019 May 20.

Institute for Molecular Medicine Finland (FIMM), Helsinki Institute of Life Science, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1371/journal.pcbi.1006752DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544320PMC
May 2019
2 Reads

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML.

Leukemia 2017 05 11;31(5):1187-1195. Epub 2016 Nov 11.

Institute for Molecular Medicine Finland, FIMM, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2016.314DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5420795PMC
May 2017
35 Reads
5 Citations
10.431 Impact Factor

HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia.

Leukemia 2017 02 8;31(2):301-309. Epub 2016 Aug 8.

Department of Hematology, Hematology Research Unit Helsinki, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2016.222DOI Listing
February 2017
20 Reads
8 Citations
10.431 Impact Factor

Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia.

Leukemia 2017 01 27;31(1):51-57. Epub 2016 Jul 27.

Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2016.202DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5220125PMC
January 2017
10 Reads
2 Citations
10.431 Impact Factor

Novel drug candidates for blast phase chronic myeloid leukemia from high-throughput drug sensitivity and resistance testing.

Blood Cancer J 2015 May 1;5:e309. Epub 2015 May 1.

Hematology Research Unit Helsinki, University of Helsinki and Department of Hematology, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/bcj.2015.30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423219PMC
May 2015
4 Reads
2 Citations
2.884 Impact Factor

Novel activating STAT5B mutations as putative drivers of T-cell acute lymphoblastic leukemia.

Leukemia 2014 Aug 27;28(8):1738-42. Epub 2014 Feb 27.

1] Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland [2] Institute of Biomedicine, University of Helsinki, Helsinki, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/leu.2014.89DOI Listing
August 2014
18 Reads
21 Citations
10.431 Impact Factor

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Cancer Discov 2013 Dec 20;3(12):1416-29. Epub 2013 Sep 20.

1Institute for Molecular Medicine Finland, FIMM; 2Hematology Research Unit Helsinki, Helsinki University Central Hospital, University of Helsinki, Helsinki; 3Department of Clinical Chemistry and TYKSLAB, Turku University Central Hospital, University of Turku, Turku; 4Department of Internal Medicine, Tampere University Hospital, Tampere, Finland; 5Department of Clinical Science, Hematology Section, University of Bergen; and 6Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Bergen, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2159-8290.CD-13-0350DOI Listing
December 2013
73 Reads
60 Citations
15.930 Impact Factor

Homologous recombination repairs secondary replication induced DNA double-strand breaks after ionizing radiation.

Nucleic Acids Res 2012 Aug 13;40(14):6585-94. Epub 2012 Apr 13.

Department of Genetics, Microbiology and Toxicology, Stockholm University, S-106 91 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gks315DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3413124PMC
August 2012
20 Reads
24 Citations
9.112 Impact Factor

Methylated DNA causes a physical block to replication forks independently of damage signalling, O(6)-methylguanine or DNA single-strand breaks and results in DNA damage.

J Mol Biol 2010 Sep 17;402(1):70-82. Epub 2010 Jul 17.

Department of Genetics, Microbiology and Toxicology, Stockholm University, S-106 91 Stockholm, Sweden.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jmb.2010.07.010DOI Listing
September 2010
32 Reads
33 Citations
4.333 Impact Factor

Top co-authors

Krister Wennerberg
Krister Wennerberg

University of North Carolina

4
Caroline A Heckman
Caroline A Heckman

University of Helsinki

4
Olli Kallioniemi
Olli Kallioniemi

University of Turku

4
Kimmo Porkka
Kimmo Porkka

University of Helsinki and Helsinki University Central Hospital

4
Satu Mustjoki
Satu Mustjoki

University of Helsinki and Helsinki University Central Hospital

3
B Yadav
B Yadav

Patan Hospital

3
Jonathan Knowles
Jonathan Knowles

UCL Eastman Dental Institute

3
A Parsons
A Parsons

University of Birmingham

3
Alun Parsons
Alun Parsons

University of Bergen; and 6Department of Internal Medicine

3
Bhagwan Yadav
Bhagwan Yadav

University of Helsinki

2